Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethical Standards I01:25

Ethical Standards I

822
The American Nurses Association (ANA) created and implemented the first nationally accepted Code of Ethics for Nurses with Interpretive Statements. The Code of Ethics is a living document regularly updated by the ANA and establishes an ethical standard that is non-negotiable for nurses in all roles and settings.
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
822
Ethical Standards II01:23

Ethical Standards II

683
Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
683
Legal Guidelines for Documentation01:06

Legal Guidelines for Documentation

1.3K
The legal guidelines for nursing documentation are essential for ensuring accurate, professional, and ethical recording of patient care. The guidelines are discussed here:
1.3K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

191
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
191
Standards of Care II01:19

Standards of Care II

658
Nurses bear specific legal responsibilities under several federal statutes, including:
658

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital Outpatient Care for Patients With Type 1 Diabetes (DigiDiaS): Pragmatic Observational Pre-Post Study.

Journal of medical Internet research·2026
Same author

Experiences from Multi-Method Testing of a Comprehensive Mobile Health App.

Studies in health technology and informatics·2026
Same author

Sustainability in Food-Based Dietary Guidelines: Digital Readiness in Nordic Versus Mediterranean Countries.

Studies in health technology and informatics·2026
Same author

Effect of a Personalized Mobile Health Intervention Using Artificial Intelligence (the WARIFA App) Versus a Nonpersonalized Intervention on User-Defined Objectives, Healthy Lifestyles, and Management of Type 1 Diabetes (T1D): Protocol for a Randomized Controlled Trial.

JMIR research protocols·2026
Same author

Feasibility and usability of a ChatGPT-based app to support physical activity: A pilot study.

Digital health·2026
Same author

Testing a mobile peer support intervention for persons with serious mental illness (DigiPer) in community mental health services: a feasibility study protocol.

BMJ open·2026

Related Experiment Video

Updated: Jul 11, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K

Privacy Concerns Related to Data Sharing for European Diabetes Devices.

Pietro Randine1,2, Matthias Pocs3, John Graham Cooper4

  • 1Department of Computer Science, Faculty of Science and Technology, UiT The Arctic University of Norway, Tromsø, Norway.

Journal of Diabetes Science and Technology
|November 14, 2023
PubMed
Summary

Diabetes management relies on connected devices, but their data sharing is often unclear. This study reveals gaps in regulatory compliance and EUDAMED registration for diabetes medical equipment and software, impacting patient data security.

Keywords:
GDPRmedical deviceprivacysecuritysoftware as medical device

More Related Videos

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.5K
Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

16.3K

Related Experiment Videos

Last Updated: Jul 11, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.5K
Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

16.3K

Area of Science:

  • Medical device regulation
  • Health informatics
  • Diabetes technology

Background:

  • Diabetes management increasingly uses connected medical equipment and mobile apps, generating valuable health data.
  • Data sharing from these devices is governed by Terms of Service (ToS) and Privacy Policies.
  • New European Union regulations (MDR/IVDR) update rules for medical devices, including software.

Purpose of the Study:

  • To examine data sharing regulations in ToS and Privacy Policies for diabetes medical equipment and software approved in Norway.
  • To assess compliance with data protection and device registration requirements.

Main Methods:

  • Document analysis of ToS and Privacy Policy documents for approved diabetes medical equipment and software in Norway.

Main Results:

  • 11 medical devices and 12 software applications were analyzed; only 3 devices were EUDAMED registered, with no software applications.
  • Compliance with General Data Protection Regulation (GDPR) security varied among software applications.
  • Non-European Economic Area companies dominate the development of diabetes medical device technology.

Conclusions:

  • Significant gaps exist in the EUDAMED registration of diabetes medical equipment and associated software.
  • Regulatory compliance and data-sharing practices require further attention to ensure patient data security.
  • The study underscores the need for enhanced oversight in the rapidly evolving field of diabetes digital health.